Chinese Journal of Pharmacovigilance ›› 2021, Vol. 18 ›› Issue (4): 396-399.
DOI: 10.19803/j.1672-8629.2021.04.22

Previous Articles     Next Articles

Active Ingredients of Ephedra and Their Clinical Application and Contraindications

REN Haibo1, WANG Yingchun1,2,3, MA Jingei1,2,3, LI Junshan2,3,4, NIU Liying1,2,3,*   

  1. 1Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050091, China;
    2Hebei TCM Formula Granule Technology Innovation Center, Shijiazhuang, Hebei 050091, China;
    3Hebei TCM Quality Evaluation and Standardization Engineering Research Center, Shijiazhuang, Hebei 050091, China;
    4Shineway Pharmaceutical Group Company Limited, Shijiazhuang, Hebei 051430, China
  • Received:2020-06-22 Online:2021-04-15 Published:2021-04-23

Abstract: Ephedra was first documented in "Shen Nong's Materia Medica". It has complex chemical components and has many pharmacological activities such as diaphoresis, relieving asthma, diuresis, lowering blood lipids and anti-oxidation. It has a wide range of clinical applications. This article reviews the active ingredients, pharmacological effects, clinical application and contraindications of Ephedra with a view to providing reference for further in-depth research and safety of clinical medication of Ephedra and its related preparations.

Key words: Ephedra, active ingredient, adverse reaction, application, contraindication

CLC Number: